Personal Economics
  • Anema Drugs Made Billions, But at What Cost?

    By Peter Whoriskey, The Washington Post

    For years, a trio of anemia drugs known as Epogen, Procrit and Aranesp ranked among the best-selling prescription drugs in the U.S., generating more than $8 billion a year for two companies, Amgen...

  • How Much More Would You Pay with Obama’s Tax Hike?

    By Josh Boak, The Fiscal Times

    The fierce debate over President Obama’s plan to hike taxes on families earning more than $250,000 a year has mostly revolved around ideologically fueled disputes about the impact on the broader...

  • 9 Desperate Money Measures Airlines Are Taking

    By Leah Konen, The Fiscal Times

    From encouraging flight attendants to slim down to shrinking seat size, the most outrageous new policies in the sky.

  • Google Internet business defies econ worries, ad clicks surge

    Google Internet business defies econ worries, ad clicks surge

    By Alexei Oreskovic, Reuters

    SAN FRANCISCO (Reuters) - Google Inc's core Internet business increased revenue by 21 percent in the second quarter, easing Wall Street worries that a slumping global economy would take a toll on the...

  • Existing home sales fall in June, prices rise

    Existing home sales fall in June, prices rise

    By Reuters

    WASHINGTON (Reuters) - Home resales fell in June but the median sales price was higher than a year earlier as fewer people sold their homes under distressed conditions, giving mixed signals for the...